EC launches innovation partnerships to foster sustainable research
02.03.2012 - With three new Innovation Partnerships, the European Commission (EC) intends to eliminate weaknesses, bottlenecks and obstacles in the European research and innovation system.
The key challenges to be met are the supply of raw materials, sustainable agriculture, and active and healthy ageing. It’s the Commission’s view that all three require a more concerted innovation effort across the public and private sector, in order to improve quality of life and position Europe as a global leader. The agricultural productivity and sustainability partnership aims at the reversal of the recent trend of diminishing productivity gains and targets to improve soil quality to a satisfactory level by 2020. In order to increase innovation supporting exploration, extraction and processing of raw materials, the Commission launched the raw materials partnership. The project is set to improve recycling of electronic equipment and other waste and calls for the development of substitutes for critical raw materials. Finally, the European Innovation Partnership on active and healthy ageing seeks solutions for the demographic change in Europe. The number of European citizens aged 65 and over will double over the next 50 years. This poses the European care and social systems to a challenge and calls for redesigning these systems in the interest of patients, healthcare systems and the innovative industry.
12.05.2015 US pharma is coming to European biotech to fill their pipeline. Pfizer is paying €77.5m for an option on Dutch AM-Pharma, while Juno Therapeutics acquired German biotech Stage Cell Therapeutics for around €72m.
26.05.2015 The Finnish Medicines Agency Fimea has joined the Dutch MEB in its stance on the interchangeability of biosimilars. The Fimea now sees physician-driven switching of biologics as unproblematic.
20.05.2015 The Scottish Government has announced it will double the amount of funds for rare diseases. The New Medicines Fund that was created last year for this purpose will be increased to £80m (€112m).
30.04.2015 The European Parliament has given the go-ahead on a new law limiting the use of harmful crop-based biofuel in the transport sector. The decision marks a breakthrough in the EU’s approach to biofuels.
SuperScript® III Reverse Transcriptase (RT) is a proprietary mutant of SuperScript® II RT that is active at 50°C and has a half-life of 220 minutes, providing increased specificity with gene-specific primers (GSPs) and the highest cDNA yield of all RTs. more